Compare AbCellera Biologics Inc (ABCL) vs NetApp Inc. (NTAP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs NetApp Inc. — how do they compare? AbCellera Biologics Inc trades at $9.2 (market cap $2.99B), while NetApp Inc. trades at $199.43 (market cap $38.95B). The key difference: NetApp Inc. is far larger — about 13× AbCellera Biologics Inc's market cap, and NetApp Inc. pays a 1.05% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | NTAP | |
|---|---|---|
Market Cap | $2.99B | $38.95B |
Sector | Health | Technology |
52-Week High | $9.76 | $198.72 |
52-Week Low | $2.78 | $94.11 |
Enterprise Value | $2.58B | $38.10B |
Dividend Yield | — | 1.05% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About NetApp Inc.
NetApp is a leading provider of enterprise data management and storage solutions. The company's three operating business units are products, software maintenance, and hardware maintenance. NetApp transitioned from a data center storage firm to a company with software data management solutions for multicloud environments. The California-headquartered company sells globally and has approximately 10,000 employees.
Read more on NTAP →
